haloperidol has been researched along with minocycline in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Hayashida, M; Horiguchi, J; Inagaki, T; Miyaoka, T; Yasuda, H; Yasukawa, R | 1 |
| Fukakusa, A; Ibi, D; Ito, Y; Kim, HC; Mizoguchi, H; Nakatani, A; Takuma, K; Yamada, K | 1 |
| Horikawa, H; Kanba, S; Kato, TA; Mizoguchi, Y; Monji, A; Sato-Kasai, M; Seki, Y; Yoshiga, D | 1 |
| Akcay, M; Arslan, H; Topcuoglu, HS; Tuncay, O | 1 |
| Avvisati, L; Buonaguro, EF; Chiodini, P; de Bartolomeis, A; Iasevoli, F; Latte, G; Marmo, F; Rossi, R; Tomasetti, C | 1 |
| Huang, J; Li, Y; Long, Y; Shen, Y; Wang, Y; Wu, R; Zhao, J | 1 |
1 review(s) available for haloperidol and minocycline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
14 other study(ies) available for haloperidol and minocycline
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Possible antipsychotic effects of minocycline in patients with schizophrenia.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Antipsychotic Agents; Electroencephalography; Haloperidol; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Minocycline; Psychiatric Status Rating Scales; Risperidone; Schizophrenia, Catatonic; Tomography, X-Ray Computed | 2007 |
Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice.
Topics: Animals; Behavior, Animal; Clozapine; Dose-Response Relationship, Drug; Exploratory Behavior; Haloperidol; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Memory Disorders; Methamphetamine; Mice; Mice, Inbred ICR; Minocycline; Mitogen-Activated Protein Kinase 3; Motor Activity; Neuroprotective Agents; Phosphorylation; Time Factors | 2008 |
Pretreatment of aripiprazole and minocycline, but not haloperidol, suppresses oligodendrocyte damage from interferon-γ-stimulated microglia in co-culture model.
Topics: Animals; Animals, Newborn; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Brain; Cell Survival; Cells, Cultured; Coculture Techniques; Drug Interactions; Haloperidol; Interferon-gamma; Microglia; Minocycline; Myelin Proteolipid Protein; Nitrites; Oligodendroglia; Piperazines; Quinolinium Compounds; Quinolones; Rats; STAT1 Transcription Factor | 2013 |
Effect of calcium hydroxide and double and triple antibiotic pastes on the bond strength of epoxy resin-based sealer to root canal dentin.
Topics: Adhesiveness; Algorithms; Anti-Bacterial Agents; Calcium Hydroxide; Ciprofloxacin; Dental Bonding; Dental Pulp Cavity; Dental Stress Analysis; Dentin; Edetic Acid; Epoxy Resins; Gutta-Percha; Humans; Materials Testing; Metronidazole; Minocycline; Random Allocation; Root Canal Filling Materials; Root Canal Irrigants; Root Canal Preparation; Sodium Hypochlorite; Stress, Mechanical; Surface Properties; Time Factors; Tooth Apex | 2014 |
Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia.
Topics: Animals; Antipsychotic Agents; Cerebral Cortex; Drug Resistance; Gene Expression; Haloperidol; Homer Scaffolding Proteins; Intracellular Signaling Peptides and Proteins; Ketamine; Male; Membrane Proteins; Minocycline; Nerve Tissue Proteins; Post-Synaptic Density; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2017 |
Minocycline and antipsychotics inhibit inflammatory responses in BV-2 microglia activated by LPS via regulating the MAPKs/ JAK-STAT signaling pathway.
Topics: Antipsychotic Agents; Haloperidol; Humans; Interleukin-6; Lipopolysaccharides; Microglia; Minocycline; Nitric Oxide; Nitric Oxide Synthase Type II; Risperidone; Signal Transduction; Tumor Necrosis Factor-alpha | 2023 |